0 Commentaires
0 Parts
159 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market Forecast 2026–2034: Growth Driven by Rising Antimicrobial Resistance and Advanced Antibiotic InnovationsGlobal Complicated Skin and Skin Structure Infections (cSSSI) Drugs Market continues to demonstrate robust growth amid rising antimicrobial resistance and increasing prevalence of hard-to-treat skin infections. Healthcare providers worldwide are facing significant challenges in managing deep tissue infections, surgical site complications, and diabetic foot ulcers - all of which require advanced...0 Commentaires 0 Parts 315 Vue 0 Aperçu
-
Phage Therapy for Antibiotic Resistance Market Size, Next-Generation Antimicrobial Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Phage Therapy for Antibiotic Resistance Market The global phage therapy for antibiotic resistance market size was valued at USD 313.63 million in 2024 and is expected to reach USD 1,116.44 million by 2032, at a CAGR of 17.20% during the forecast period The data, information,...0 Commentaires 0 Parts 341 Vue 0 Aperçu
-
Phage Therapy for Antibiotic Resistance Market Size, Next-Generation Antimicrobial Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Phage Therapy for Antibiotic Resistance Market The global phage therapy for antibiotic resistance market size was valued at USD 313.63 million in 2024 and is expected to reach USD 1,116.44 million by 2032, at a CAGR of 17.20% during the forecast period The data, information,...0 Commentaires 0 Parts 366 Vue 0 Aperçu
-
Tackling Antimicrobial Resistance (AMR): Market Dynamics and Novel Anti-Infective Innovations (2026–2033)The global healthcare landscape is witnessing critical structural transformations, placing infectious disease management at the center of clinical priorities. According to recent comprehensive industry tracking, the global Anti-Infective Drugs Market—which was valued at USD 135 billion in 2022 and climbed toward USD 184.7 billion by 2030—is maintaining an architectural shift in...0 Commentaires 0 Parts 90 Vue 0 Aperçu
-
The Antimicrobial Resistance Challenge: How the Clostridium Difficile Associated Disease Market Is RespondingClostridium difficile (C. diff) is a bacterium that causes a potentially life-threatening gastrointestinal infection, typically triggered by the disruption of normal gut flora following antibiotic use. The rising incidence of these infections, coupled with growing antibiotic resistance and high recurrence rates, represents a significant public health challenge. The Clostridium Difficile...0 Commentaires 0 Parts 79 Vue 0 Aperçu
-
UK Antibiotic Resistance Market - NHS Antimicrobial Stewardship Achieving National CoverageMarket Overview The UK antibiotic resistance market is maturing as NHS antimicrobial stewardship achieves national coverage across English healthcare trusts and devolved nation health services. The UK Antibiotic Resistance Market is projected to grow through 2030, driven by increasing NHS England AMS mandates, growing integration of stewardship in CQUIN frameworks, rising complexity of...0 Commentaires 0 Parts 171 Vue 0 Aperçu
-
Bacterial Vaccines Market to Hit $47.93 Billion by 2032.Introspective Market Research (IMR) today unveiled a comprehensive analysis of the Global Bacterial Vaccines Market, forecasting a monumental rise in demand over the next decade. According to the report, the market was valued at USD 23.78 billion in 2023 and is projected to reach USD 47.93 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.10% from 2024 to 2032. This surge is...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentaires 0 Parts 778 Vue 0 Aperçu
-
Clinical Microbiology Market - Size & Industry AnalysisIntrospective Market Research, a leading authority in healthcare and life sciences market intelligence, today published its comprehensive analysis of the Global Clinical Microbiology Market. This vital sector encompasses diagnostic instruments, reagents, and automated systems used for the identification, isolation, and susceptibility testing of infectious pathogens, playing a pivotal role in...0 Commentaires 0 Parts 4KB Vue 0 Aperçu
-
Global Ceftazidime Avibactam Market Insights & Growth Trends | CAGR 9.7% (2026–2034)According to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Respiratory Tract Infection Treatment Market - Share Analysis (2024–2032)Introspective Market Research (IMR) has released a critical analysis of the Global Respiratory Tract Infection (RTI) Treatment Market, highlighting its rapid expansion fueled by persistent global health challenges. RTIs, including pneumonia, bronchitis, and sinusitis, remain a leading cause of morbidity and mortality worldwide. The market, which was valued at USD 40.20 Billion in 2023, is...0 Commentaires 0 Parts 4KB Vue 0 Aperçu
-
Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
Bengali